HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution
Open Access
- 1 June 2016
- journal article
- research article
- Published by Elsevier in Virus Research
- Vol. 218, 57-70
Abstract
No abstract availableKeywords
Funding Information
- Swiss National Science Foundation (310030_152663)
This publication has 88 references indexed in Scilit:
- Development of prophylactic vaccines against HIV-1Retrovirology, 2013
- Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivoProceedings of the National Academy of Sciences, 2012
- Antiretroviral dynamics determines HIV evolution and predicts therapy outcomeNature Medicine, 2012
- Transmembrane Domain Membrane Proximal External Region but Not Surface Unit–Directed Broadly Neutralizing HIV-1 Antibodies Can Restrict Dendritic Cell–Mediated HIV-1 Trans-infectionThe Journal of Infectious Diseases, 2012
- Cell-to-Cell Transfer of HIV-1 via Virological Synapses Leads to Endosomal Virion Maturation that Activates Viral Membrane FusionCell Host & Microbe, 2011
- The Antibody Response against HIV-1Cold Spring Harbor Perspectives in Medicine, 2011
- Broad neutralization coverage of HIV by multiple highly potent antibodiesNature, 2011
- Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodiesJournal of Experimental Medicine, 2011
- Rational antibody-based HIV-1 vaccine design: current approaches and future directionsCurrent Opinion in Immunology, 2010
- Retroviruses can establish filopodial bridges for efficient cell-to-cell transmissionNature Cell Biology, 2007